New Zealand markets closed

Sunflower Pharmaceutical Group Co.,Ltd (002737.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
23.64-0.12 (-0.50%)
As of 10:36AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 13.88B
Enterprise value 10.11B
Trailing P/E 14.31
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.54
Price/book (mrq)2.76
Enterprise value/revenue 1.85
Enterprise value/EBITDA 8.56

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-2.38%
S&P500 52-week change 323.20%
52-week high 330.79
52-week low 320.54
50-day moving average 327.86
200-day moving average 325.97

Share statistics

Avg vol (3-month) 38.47M
Avg vol (10-day) 39.87M
Shares outstanding 5584M
Implied shares outstanding 6615.57M
Float 8246.7M
% held by insiders 157.14%
% held by institutions 110.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.5
Forward annual dividend yield 46.31%
Trailing annual dividend rate 31.50
Trailing annual dividend yield 36.31%
5-year average dividend yield 44.70
Payout ratio 460.24%
Dividend date 3N/A
Ex-dividend date 414 Jun 2024
Last split factor 22:1
Last split date 318 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 17.75%
Operating margin (ttm)20.14%

Management effectiveness

Return on assets (ttm)8.58%
Return on equity (ttm)19.68%

Income statement

Revenue (ttm)5.45B
Revenue per share (ttm)9.36
Quarterly revenue growth (yoy)-14.00%
Gross profit (ttm)N/A
EBITDA 1.13B
Net income avi to common (ttm)968.19M
Diluted EPS (ttm)1.66
Quarterly earnings growth (yoy)-37.20%

Balance sheet

Total cash (mrq)3.8B
Total cash per share (mrq)6.5
Total debt (mrq)26.74M
Total debt/equity (mrq)0.51%
Current ratio (mrq)3.36
Book value per share (mrq)8.60

Cash flow statement

Operating cash flow (ttm)844.95M
Levered free cash flow (ttm)414.62M